U.S. Electronic Equipment and Components Stock News

Why Walker & Dunlop (WD) is on investors’ radar today Walker & Dunlop (WD) has drawn investor attention after a period of weaker share performance, with the stock showing negative returns over the past year and past 3 months. This has prompted some investors to take a closer look at its fundamentals. At a last close of US$46.01, the company sits against a backdrop of mixed signals. These include a value score of 1 and recently reported annual revenue of US$1,160.01m alongside net income of...

In late February 2026, SouthState Bank was caught up in a broad financial sector pullback after hotter-than-expected U.S. producer inflation data and renewed concerns about banks’ credit quality and loan performance. The episode underscored how macroeconomic inflation surprises and shifting expectations for Federal Reserve policy can quickly alter sentiment toward regional lenders’ balance-sheet risks. Next, we’ll examine how these inflation and credit-quality concerns interact with...

If you are wondering whether Microsoft is still priced attractively or if the best days are already reflected in the share price, this article walks through what the numbers indicate about its current valuation. Microsoft shares last closed at US$392.74, with returns of a 1.1% decline over 7 days, a 9.4% decline over 30 days, a 17.0% decline year to date, a 0.3% decline over 1 year, 57.5% over 3 years and 76.7% over 5 years. This gives you a broad sense of how the stock has behaved across...

In late February 2026, ANI Pharmaceuticals, Inc. reported past fourth-quarter 2025 sales of US$247.06 million and net income of US$27.49 million, alongside full-year 2025 sales of US$883.37 million and a swing to profitability. The company also reaffirmed its 2026 revenue outlook of US$1.06 billion to US$1.12 billion, underpinned by strong rare disease and generics performance, including expanded uptake of Cortrophin Gel. Now we’ll examine how this record 2025 performance and reaffirmed...

In February 2026, Vaxcyte reported a full-year 2025 net loss of US$766.63 million and higher loss per share, while also raising roughly US$408.10 million through an at-the-market follow-on equity offering and filing additional shelf capacity linked to employee stock plans. Alongside these financing moves, the company highlighted unprecedented Phase 2 results for its VAX-31 pneumococcal vaccine, rapid progression into multiple Phase 3 trials, and completion of a large-scale manufacturing...

Collegium Pharmaceutical (COLL) shares came under pressure after its Q4 and full year 2025 report, where earnings and revenue missed some analyst estimates, while management reaffirmed and slightly lifted 2026 guidance. See our latest analysis for Collegium Pharmaceutical. The Q4 miss has come with a reset in expectations, with the 1 day share price return of a 5.77% decline at US$41.67 extending a 30 day share price return of a 9.26% decline, even though the 1 year total shareholder return...

Xponential Fitness (XPOF) is back in focus after reporting fourth quarter and full year 2025 results, along with 2026 revenue guidance that points to a lower range than the prior year. See our latest analysis for Xponential Fitness. The earnings release and lower 2026 revenue guidance have coincided with sharp share price weakness, with a 1 day share price return of 47.08% decline and a 1 year total shareholder return of 67.75% decline. This points to fading momentum and a reassessment of...

If you are wondering whether Vulcan Materials is a fair deal at around US$310 per share, it helps to step back and look at what the current price actually reflects. The stock last closed at US$310.00, with returns of 1.5% over 7 days, 3.1% over 30 days, 5.9% year to date, 26.3% over 1 year, 73.4% over 3 years and 92.3% over 5 years, which may shape how investors are thinking about its potential and its risks today. Recent coverage has focused on Vulcan Materials as a key supplier of...

MDU Resources Group’s board recently declared a quarterly dividend of US$0.14 per share, unchanged from the prior quarter, payable on April 1, 2026 to shareholders of record on March 12, 2026, while continuing to target a long-term payout ratio of 60% to 70% of earnings. Alongside reaffirmed earnings guidance and a multi-year US$3.10 billion capital plan as a pure-play regulated utility and pipeline operator, the full exit of activist investor Corvex Management highlights an evolving...

In February 2026, Array Digital Infrastructure reported fourth-quarter 2025 revenue of US$60.33 million and net income of US$37.48 million, while issuing 2026 revenue guidance of US$200 million to US$215 million as it pivots toward tower and site rental income after selling regional wireless operations and most spectrum licenses. This shift is reshaping the company into a largely tower-focused business, with earnings now more closely tied to long-term lease agreements with major carriers...

Mirum Pharmaceuticals stock snapshot after recent performance shifts Mirum Pharmaceuticals (MIRM) has had mixed share-price moves recently, with a small 1 day gain, a 12% decline over the past week, a 10% drop over the past month, and a 32% gain across the past 3 months. Against that backdrop, investors are weighing Mirum’s current US$92.29 share price, its recent return profile over the past year and beyond, and how that lines up with the company’s rare disease portfolio and financial...

In late February 2026, LandBridge Company LLC reported past fourth-quarter revenue of US$56.78 million and net income of US$8.06 million, alongside full-year 2025 revenue of US$199.09 million and net income of US$30.13 million, while also announcing a 20% dividend increase and a new US$50 million share repurchase program. This combination of strong earnings growth, a higher cash dividend, and a sizable buyback authorization underscores management’s confidence in LandBridge’s capital-light...

In February 2026, Planet Fitness reported higher Q4 and full-year 2025 revenue and earnings, alongside guidance for 2026 calling for approximately 9% revenue growth. At the same time, the company’s moderated growth outlook and ongoing legal investigations contrasted with continued international expansion, including new franchise-backed clubs in northern Mexico. We’ll now examine how Planet Fitness’s tempered 2026 guidance, despite solid 2025 results, reshapes the company’s longer-term...

On February 26, 2026, Bank of New York Mellon Corporation priced and completed a US$500,000,000 underwritten public offering of 500,000 Series M Noncumulative Perpetual Preferred Stock depositary shares at US$1,000 each, featuring callable, non-cumulative, variable-rate terms. The planned use of proceeds for general corporate purposes, including potential redemptions of existing Series F and Series H preferred stock, signals a meaningful reshaping of BNY’s capital structure and future...

In recent days, Cathay General Bancorp has come under pressure as investors reacted to rising credit risk concerns amid hotter-than-expected inflation data and growing worries over regional banks’ exposure to commercial real estate. What makes this episode especially important is that it coincides with Cathay General’s flat sales and declining earnings per share, sharpening questions about its profitability and growth profile. We’ll now examine how heightened credit risk concerns,...

SL Green Realty recently reported past leasing gains in Manhattan, signing 56 office leases covering 0.8 million square feet and completing major portfolio moves, including the US$730,000,000 acquisition of Park Avenue Tower and a 49% joint venture sale in 100 Park Avenue, alongside higher average rental rates. An interesting takeaway is how this combination of stronger leasing, higher rents, and active portfolio reshaping is helping offset the earnings pressure created by rising interest...

In late February 2026, Viridian Therapeutics reported fourth-quarter and full-year 2025 results showing modest revenue but a larger net loss alongside a new US$16.33 million shelf registration for employee stock offerings. At the same time, the company’s thyroid eye disease program advanced with veligrotug under FDA Priority Review and an EMA filing submitted, reinforcing its focus on late-stage assets despite higher losses. With these regulatory milestones for veligrotug in place, we’ll now...

Earnings, guidance and capital returns in focus Bristow Group (VTOL) just paired its fourth quarter and full year 2025 results with 2026 guidance, a fresh quarterly dividend and details on a recent US$500 million refinancing at a lower coupon. The company reported Q4 2025 sales of US$377.26 million and net income of US$18.42 million, while affirming 2026 revenue expectations in a US$1.58 billion to US$1.69 billion range and maintaining its new US$0.125 quarterly cash dividend. See our latest...

Knight-Swift Transportation Holdings (KNX) is back in focus after its fourth-quarter 2025 adjusted earnings per share of US$0.31 came in below analyst expectations, along with fresh insider selling by the company’s CFO. See our latest analysis for Knight-Swift Transportation Holdings. The recent earnings miss and CFO share sale come against a backdrop of strong recent momentum. A 30 day share price return of 14.19% and a 1 year total shareholder return of 26.67% suggest sentiment has improved...

Manhattan Associates has announced that long-serving CFO and Executive Vice President Dennis Story will retire from his roles on March 31, 2026, with veteran finance executive Linda Pinne stepping in as Chief Financial Officer, Chief Accounting Officer, and Treasurer while Story remains an advisor to the CEO through year-end 2026. This carefully staged handover, elevating a 20-year company insider who already oversees accounting and treasury, signals an emphasis on continuity in financial...

In late February 2026, California Resources Corporation received its third ‘Grade A’ MiQ methane certification covering most of its San Joaquin Valley production in Fresno and Kern Counties, underscoring independently verified low-methane operations across the majority of its portfolio. This expanded certification could enhance CRC’s positioning in California’s Low Carbon Fuel Standard market, where lower-methane barrels may command a pricing premium and support its broader decarbonization...

Why Masimo is on investor watchlists right now Masimo (MASI) has recently drawn fresh attention after a strong month in the stock, with returns over the past 3 months also standing out against a weaker 1 year total return. See our latest analysis for Masimo. The recent 27.69% 1 month share price return and 21.75% 3 month share price return, against a 1 year total shareholder return decline of 7.11%, suggests short term momentum has picked up while longer term holders are still under water at...

In late February 2026, Zoom Communications reported fourth-quarter revenue of about US$1.25 billion and net income of US$674.08 million, capping a full year with sales of US$4.87 billion and net income of US$1.90 billion, alongside new guidance for fiscal 2027 and completion of a US$2.70 billion share buyback program. Beyond its core operations, Zoom highlighted growing traction in AI-powered products and the potential value of its early-stage investment in Anthropic, which some commentators...

In February 2026, Lithia Motors’ board amended its bylaws to remove the upper limit on board size and set the director count at 10 for the 2026 annual shareholder meeting. Around the same time, JPMorgan shifted to a more cautious stance on Lithia Motors, highlighting execution visibility, cost control challenges, and higher balance sheet leverage despite an otherwise constructive industry backdrop. We’ll now examine how JPMorgan’s concerns about execution and cost control may affect Lithia...